Researchers at institutions including the University of Pennsylvania and NIH are currently conducting formal clinical trials to study whether GLP-1 agonists could be used as treatments for alcohol use disorder
Venous Ulcers Cause: Venous hypertension and valve failure poor venous return Typical features: Location: medial gaiter area (ankle/lower leg), rarely toes Appearance: shallow, irregular edges Exudate: often heavy Skin changes: oedema, hyperpigmentation, lipodermatosclerosis Pain: mild to moderate, improves with elevation Management focus: Compression therapy (once arterial disease excluded) Skin care and oedema control Wound dressings to manage exudate Arterial Ulcers Cause: Peripheral arterial disease (reduced blood flow) Typical features: Location: toes, forefoot, heel, pressure points Appearance: punched-out, deep, often necrotic Exudate: minimal Skin changes: cool, pale, shiny, hair loss Pain: severe, worse at night or when leg is elevated Management focus: Urgent vascular assessment Revascularisation where possible Avoid compression until perfusion is confirmed Why this distinction is critical Compression heals venous ulcers but can destroy an ischaemic limb Debridement may be appropriate in venous ulcers but dangerous in arterial disease without blood flow Dressing choice, escalation, and prognosis differ significantly Key message Treating an ulcer without understanding its cause is treating blind
.jpeg)
Always opt for lyophilised peptides and reconstitute them just before use to ensure maximum efficacy in your research
If you are taking any medications, consult your doctor before use
How should "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg be stored and handled
